1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Ciclopirox: new trials by email Literature Review of Ciclopirox trials Research Report on Ciclopirox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP ATL-001 (Ciclopirox oral solution) - Congenital Erythropoietic Porphyria (CEP) | Phase 1 / Phase 2 | Recruiting | Atlas Molecular Pharma | 6 | 2026-01-29 | 2026-03-24 |
| The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis CELEXT07, Penlac, vehicle solution - Onychomycosis | Phase 2 | Unknown | 9305-9954 Quebec Inc | 120 | 2016-11-01 | 2017-04-26 |
Onychomycosis (1) · Porphyria, Erythropoietic (1)
9305-9954 Quebec Inc (1) · Atlas Molecular Pharma (1)
Canada (1) · United States (1)